Cell therapy processing market to reach $9.93B by 2030 at 13.8% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Cell Therapy Processing Market Progress Between 2026 And 2030?
The cell therapy processing market size has experienced rapid expansion over recent years. It is anticipated to increase from $5.18 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. Historically, this growth can be linked to an increase in clinical trials for cell therapies, the expansion of biopharmaceutical manufacturing capacity, the availability of specialized processing facilities, developing expertise in GMP compliance, and heightened investment in advanced therapeutics.
The cell therapy processing market is projected for substantial expansion in the coming years, with its size anticipated to reach $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This projected growth is driven by factors such as the expanding commercialization of gene and cell therapies, a heightened demand for contract manufacturing services, the proliferation of decentralized manufacturing approaches, an increasing uptake of digital quality management systems, and a rise in regulatory approvals for cell-based treatments. Key trends expected during this period involve the greater adoption of GMP-compliant processing platforms, an escalating need for scalable cell therapy manufacturing, the wider integration of workflow automation software, a broadening of contract processing services, and an intensified emphasis on maintaining sterility and ensuring quality.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report
Which Major Drivers Are Influencing The Expansion Of The Cell Therapy Processing Market?
An anticipated increase in cell therapy research initiatives is set to fuel the expansion of the cell therapy processing market. Cell therapy involves creating therapeutic agents from living cells to address or manage diverse illnesses such as cancers, autoimmune conditions, and genetic ailments. The increasing need for consistent and scalable manufacturing platforms capable of handling high cell densities without affecting product quality is contributing to the heightened demand for cell-based therapies. For cell therapy research, cell therapy processing proves advantageous by allowing for the standardized preparation, quality assurance, and mass production of high-quality cells, thereby guaranteeing dependable and consistent results for both experimental and clinical investigations. An illustrative example is from December 2024, where the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, reported that six novel cell and gene therapies were launched in 2023, representing a 50% increase over the three introduced in 2022. Consequently, the expanding volume of cell therapy research activities is a key driver for the growth of the cell therapy processing market.
What Segment Categories Shape The Cell Therapy Processing Market Segment Landscape?
The cell therapy processing market covered in this report is segmented –
1) By Offering Type: Products, Services, Software
2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications
3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users
Subsegments:
1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents
2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services
3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software
Which Trends Are Shaping The Cell Therapy Processing Market?
Leading companies in the cell therapy processing market are concentrating on creating advanced solutions, particularly integrated bioreactor-centrifuge systems. These innovations aim to streamline manufacturing processes and improve the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system operates as a combined unit, incorporating cell incubation and centrifugal separation within a single, sealed environment. This enables continuous, automated cell processing without requiring intermediate transfers. For instance, in March 2025, Limula SA, a Switzerland-based company focused on cell and gene therapy (CGT), introduced LimONE. This automated, closed-system platform for cell therapy manufacturing brings together hardware, single-use consumables, and protocol-driven software. It condenses complex cell processing steps, such as incubation, centrifugation, and reagent handling, into one compact device, supporting the consistent and scalable production of therapies like CAR-T and gene-edited stem cells from research stages up to GMP-compliant manufacturing, without complex technology transfers.
Who Are The Companies Operating Across The Cell Therapy Processing Market Value Chain?
Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.
Get The Full Cell Therapy Processing Market Report:
https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report
Which Region Holds The Highest Market Share In The Cell Therapy Processing Market?
North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cell Therapy Processing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report
Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company
Exterior Insulation And Finish System Market Report 2026
Metal Structural Insulation Panels Market Report 2026
Vacuum Insulation Panel Market Report 2026
https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
